The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophrenia.
Saved in:
| Title: | The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophrenia. |
|---|---|
| Authors: | Bitter, Istvan (AUTHOR), Katona, Lajos (AUTHOR), Falkai, Peter (AUTHOR), Czobor, Pal (AUTHOR) |
| Source: | European Archives of Psychiatry & Clinical Neuroscience. Aug2025, Vol. 275 Issue 5, p1521-1523. 3p. |
| Subjects: | Schizophrenia, Drug therapy, Medical care research, Comparative studies, Empirical research, Medical protocols, Clinical trials |
| Abstract: | The quantity and quality of real-world data and real-world evidence in schizophrenia research are at a high level. However, these results are not included in the grading systems used to develop treatment guidelines for schizophrenia. A meta-analysis and a network meta-analysis have independently provided evidence that the results of randomized clinical trials in schizophrenia adequately translate to real-world settings. The authors propose the incorporation of a synthesis of evidence derived from analyses of randomized controlled trials and real-world data as a novel and highest level of evidence in grading instruments used to develop treatment guidelines for schizophrenia. [ABSTRACT FROM AUTHOR] |
| Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 186711334 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophrenia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Bitter%2C+Istvan%22">Bitter, Istvan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Katona%2C+Lajos%22">Katona, Lajos</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falkai%2C+Peter%22">Falkai, Peter</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Czobor%2C+Pal%22">Czobor, Pal</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Aug2025, Vol. 275 Issue 5, p1521-1523. 3p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+therapy%22">Drug therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+care+research%22">Medical care research</searchLink><br /><searchLink fieldCode="DE" term="%22Comparative+studies%22">Comparative studies</searchLink><br /><searchLink fieldCode="DE" term="%22Empirical+research%22">Empirical research</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+protocols%22">Medical protocols</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+trials%22">Clinical trials</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The quantity and quality of real-world data and real-world evidence in schizophrenia research are at a high level. However, these results are not included in the grading systems used to develop treatment guidelines for schizophrenia. A meta-analysis and a network meta-analysis have independently provided evidence that the results of randomized clinical trials in schizophrenia adequately translate to real-world settings. The authors propose the incorporation of a synthesis of evidence derived from analyses of randomized controlled trials and real-world data as a novel and highest level of evidence in grading instruments used to develop treatment guidelines for schizophrenia. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=186711334 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00406-024-01938-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 3 StartPage: 1521 Subjects: – SubjectFull: Schizophrenia Type: general – SubjectFull: Drug therapy Type: general – SubjectFull: Medical care research Type: general – SubjectFull: Comparative studies Type: general – SubjectFull: Empirical research Type: general – SubjectFull: Medical protocols Type: general – SubjectFull: Clinical trials Type: general Titles: – TitleFull: The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophrenia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bitter, Istvan – PersonEntity: Name: NameFull: Katona, Lajos – PersonEntity: Name: NameFull: Falkai, Peter – PersonEntity: Name: NameFull: Czobor, Pal IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09401334 Numbering: – Type: volume Value: 275 – Type: issue Value: 5 Titles: – TitleFull: European Archives of Psychiatry & Clinical Neuroscience Type: main |
| ResultId | 1 |